Neurocrine Biosciences Inc (NASDAQ:NBIX)

117.06
Delayed Data
As of Jan 22
 +1.91 / +1.66%
Today’s Change
72.14
Today|||52-Week Range
136.26
+22.13%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 121.50, with a high estimate of 145.00 and a low estimate of 90.00. The median estimate represents a +3.79% increase from the last price of 117.06.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.60
Sales
$263.5M
Reporting Date
Feb 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 196.69%
 
 
 
 
 
 
Growthannually 207.46%
 
 
 
 
 
 

Sales

Growthquarterly 1.95%
 
 
 
 
 
 
Growthannually 34.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.